WaveMan · Form 4
Sandell Scott D insider trades
> Search tickers & screens ⌘K
LIVE

Sandell Scott D insider trades

Sandell Scott D has filed 67 Form 4s with the SEC that we hold, for Cloudflare, Inc. (NET) (Director), Coursera, Inc. (COUR) (Director), NEUE (Director, 10% owner) and Robinhood Markets, Inc. (HOOD) (Director), among 21 companies in all. Across all of them we count 8 purchases worth $34.1M and 52 sales worth $35.8M reported on Form 4. In the last 12 months: 2 purchases ($17.3M) and 0 sales ($0). The largest single trade was a purchase of 937,500 shares of SpyGlass Pharma, Inc. worth $15.0M, dated 2026-02-09. The first filing on our record is dated 2021-07-01 and the latest 2026-07-02.

Cloudflare, Inc. (NET)

Director · 13 filings · 16 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-14S, sale reported on Form 43,927$415.2K2022-02-15
2022-02-14S, sale reported on Form 41,053$110.4K2022-02-15
2022-02-14S, sale reported on Form 4400$43.1K2022-02-15
2022-02-14S, sale reported on Form 41,242$132.6K2022-02-15
2022-06-14S, sale reported on Form 4500$20.7K2022-06-16
2022-06-14S, sale reported on Form 41,941$79.2K2022-06-16
2023-08-08S, sale reported on Form 46,570$437.4K2023-08-09
2023-08-08S, sale reported on Form 42,944$192.2K2023-08-09
2023-08-08S, sale reported on Form 49,455$610.2K2023-08-09
2023-08-08S, sale reported on Form 41,338$85.4K2023-08-09
2023-11-20S, sale reported on Form 434,611$2.5M2023-11-22
2023-11-20S, sale reported on Form 412,558$923.0K2023-11-22
2023-11-20S, sale reported on Form 428,442$2.1M2023-11-22
2023-11-20S, sale reported on Form 417,621$1.3M2023-11-22
2023-11-20S, sale reported on Form 478,389$5.7M2023-11-22
2023-11-20S, sale reported on Form 439,913$2.9M2023-11-22

Coursera, Inc. (COUR)

Director · 9 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

NEUE

Director, 10% owner · 9 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-02S, sale reported on Form 4900$6.1K2025-10-06
2025-10-02S, sale reported on Form 42,455$16.6K2025-10-06
2025-10-02S, sale reported on Form 4280$1.9K2025-10-06

Robinhood Markets, Inc. (HOOD)

Director · 9 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-31S, sale reported on Form 42,082$29.6K2022-02-01
2022-05-03S, sale reported on Form 41,952$19.6K2022-05-04
2022-05-12S, sale reported on Form 44,396$37.0K2022-05-16

Bloom Energy Corp (BE)

Director · 6 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Crescent Biopharma, INC. (GLYC)

10% owner · 3 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-30S, sale reported on Form 454,645$165.0K2023-01-04
2022-12-30S, sale reported on Form 466,690$201.4K2023-01-04
2023-01-03S, sale reported on Form 496,084$287.3K2023-01-04
2023-01-03S, sale reported on Form 478,730$235.4K2023-01-04
2023-01-04S, sale reported on Form 445,930$133.7K2023-01-04
2023-01-04S, sale reported on Form 456,054$163.1K2023-01-04
2023-01-05S, sale reported on Form 439,223$108.3K2023-01-06
2023-01-05S, sale reported on Form 432,139$88.7K2023-01-06
2023-01-25S, sale reported on Form 4293,645$957.3K2023-01-27
2023-01-25S, sale reported on Form 4358,371$1.2M2023-01-27
2023-01-26S, sale reported on Form 41,648,908$5.1M2023-01-27
2023-01-26S, sale reported on Form 41,351,092$4.2M2023-01-27

Trevi Therapeutics, Inc. (TRVI)

10% owner · 3 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-18P, purchase reported on Form 41,851,852-2021-10-19
2022-04-11P, purchase reported on Form 42,631,578$5.0M2022-04-13
2022-04-11P, purchase reported on Form 4948,948$1.8M2022-04-13

ACLX

10% owner · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-21S, sale reported on Form 4179$5.5K2022-12-22
2022-12-23S, sale reported on Form 4195$6.2K2022-12-27

Korro Bio, Inc. (KRRO)

10% owner · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-04-22P, purchase reported on Form 417,857$1,000.0K2024-04-24
2026-03-10P, purchase reported on Form 4207,100$2.3M2026-03-12

AKUS

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

AVEO

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Ardelyx, INC. (ARDX)

10% owner · 1 filing · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-09S, sale reported on Form 4144,533$218.2K2021-12-27
2021-12-09S, sale reported on Form 4397,124$599.7K2021-12-27
2021-12-09S, sale reported on Form 4127,826$193.0K2021-12-27
2021-12-14S, sale reported on Form 4216,049$267.9K2021-12-27
2021-12-14S, sale reported on Form 4593,612$736.1K2021-12-27
2021-12-14S, sale reported on Form 4191,074$236.9K2021-12-27
2021-12-15S, sale reported on Form 4888,185$1.0M2021-12-27
2021-12-15S, sale reported on Form 4323,167$368.4K2021-12-27

Enliven Therapeutics, Inc. (IMRA)

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-30S, sale reported on Form 421,858$50.1K2022-01-03
2021-12-31S, sale reported on Form 449,953$112.4K2022-01-03
2022-01-03S, sale reported on Form 444,665$104.5K2022-01-03

GNCA

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-24S, sale reported on Form 45,931,843$415.2K2022-05-26
2022-05-25S, sale reported on Form 44,445,093$355.6K2022-05-26

IonQ, Inc. (IONQ)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MBX Biosciences, Inc. (MBX)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-09-16P, purchase reported on Form 4500,000$8.0M2024-09-17

MTCR

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-10S, sale reported on Form 437,570$49.6K2021-12-27
2021-12-22S, sale reported on Form 4288,768$288.8K2021-12-27
2021-12-22S, sale reported on Form 4170,932$155.5K2021-12-27

Mirum Pharmaceuticals, Inc. (MIRM)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Sagimet Biosciences Inc. (SGMT)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Savara Inc (SVRA)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-07-17P, purchase reported on Form 4333,333$1,000.0K2023-07-19

SpyGlass Pharma, Inc. (SGP)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-02-09P, purchase reported on Form 4937,500$15.0M2026-02-11
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1237289) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms